Engin Yapici·Apr 21I Stress-Tested the AWS-MSK Nanobody Paper. These Are the Gaps.Technical analysis of an agent-guided de novo nanobody design campaign
Engin Yapici·Jan 20Origin-1: Absci’s De Novo Antibody Design PlatformMicromolar hits with structural validation but therapeutic gaps.
Engin Yapici·Dec 30, 2025Low Immunogenicity in Human Panels? Examining Latent-X2’s EvidenceAnalyzing the immunogenicity assay quality and binding validation in the first AI antibody study to test human immune responses
Engin Yapici·Dec 2, 2025JAM-2: Performance Metrics and Validation GapsTechnical analysis of Nabla Bio’s computational antibody design platform
